1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Vitrolife AB (publ)
  6. Summary
    VITR   SE0011205202

VITROLIFE AB (PUBL)

(VITR)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 05/19 09:01:53 am
239 SEK   +1.44%
04/29New Interim CFO at BICO
AQ
04/28VITROLIFE AB (PUBL) : Ex-dividend day for final dividend
FA
04/27Report from Annual General Meeting of Vitrolife AB (publ)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
05/13/2022 05/16/2022 05/17/2022 05/18/2022 05/19/2022 Date
231.6(c) 234.2(c) 239.6(c) 235.6(c) 238.2 Last
173 307 133 079 141 340 152 024 440 833 Volume
+3.95% +1.12% +2.31% -1.67% +1.10% Change
More quotes
Estimated financial data (e)
Sales 2022 3 136 M 313 M 313 M
Net income 2022 443 M 44,3 M 44,3 M
Net Debt 2022 1 703 M 170 M 170 M
P/E ratio 2022 72,1x
Yield 2022 0,45%
Sales 2023 3 656 M 365 M 365 M
Net income 2023 620 M 62,0 M 62,0 M
Net Debt 2023 1 060 M 106 M 106 M
P/E ratio 2023 51,4x
Yield 2023 0,56%
Capitalization 31 899 M 3 188 M 3 188 M
EV / Sales 2022 10,7x
EV / Sales 2023 9,02x
Nbr of Employees 1 172
Free-Float 54,4%
More Financials
Company
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for... 
More about the company
Ratings of Vitrolife AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about VITROLIFE AB (PUBL)
04/29New Interim CFO at BICO
AQ
04/28VITROLIFE AB (PUBL) : Ex-dividend day for final dividend
FA
04/27Report from Annual General Meeting of Vitrolife AB (publ)
AQ
04/27Vitrolife AB Approves Dividend for the Financial Year 2021
CI
04/22TRANSCRIPT : Vitrolife AB, Q1 2022 Earnings Call, Apr 22, 2022
CI
04/22INTERIM REPORT JANUARY-MARCH 2022 : Building on our strong growth momentum
AQ
04/08Conference call interim report
AQ
03/28Notice of Annual General Meeting of Vitrolife AB (publ)
AQ
03/28Vitrolife AB Proposes Dividend
CI
03/22Resolution on notice of Annual General Meeting of Vitrolife AB (publ)
AQ
03/20VITROLIFE AB(OM : VITR) added to FTSE All-World Index
CI
02/24Interim report January-December 2021
AQ
02/16TRANSCRIPT : Vitrolife AB, 2021 Earnings Call, Feb 16, 2022
CI
02/16REPORT ON OPERATIONS 2021 : Continuous growth and a new Vitrolife
AQ
02/16Vitrolife AB Proposes Dividend
CI
More news
News in other languages on VITROLIFE AB (PUBL)
04/27Vitrolife AB (publ) approuve le dividende pour l'exercice 2021
04/22Point sur les fortes variations du jour
04/08OPA : ¿Scout24 será el próximo objetivo del private equity?
04/08OPA : Scout24 prochaine cible du private equity ?
03/28Vitrolife AB (Publ) propose un dividende
More news
Chart VITROLIFE AB (PUBL)
Duration : Period :
Vitrolife AB (publ) Technical Analysis Chart | VITR | SE0011205202 | MarketScreener
Technical analysis trends VITROLIFE AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 235,60 SEK
Average target price 433,00 SEK
Spread / Average Target 83,8%
EPS Revisions
Managers and Directors
Hans Thomas Axelsson Chief Executive Officer
Patrik Tolf Chief Financial Officer
Sigurdur Jón Sigurðsson Chairman
Claus Bisgaard Vice President-Technology
Carlos Antonio Simon Valles Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
VITROLIFE AB (PUBL)-57.93%3 188
ABBOTT LABORATORIES-19.89%197 401
MEDTRONIC PLC0.12%138 943
BECTON, DICKINSON AND COMPANY2.17%71 580
HOYA CORPORATION-25.01%36 535
BAXTER INTERNATIONAL INC.-15.98%36 314